BioCryst Pharmaceuticals BCRX Number of reportable segments
Number of reportable segments at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NumberOfReportableSegments.
The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's number of reportable segments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's number of reportable segments?
- BioCryst Pharmaceuticals (BCRX) reported number of reportable segments of 1 in Q1 2026.
- How has BioCryst Pharmaceuticals's number of reportable segments changed year-over-year?
- BioCryst Pharmaceuticals's number of reportable segments decreased by 0.0% year-over-year, from 1 to 1.
- What does number of reportable segments mean?
- The number of business or geographic segments that meet the quantitative thresholds for separate disclosure under accounting standards. This reflects the company's primary drivers of revenue and the level of transparency provided regarding different business lines.